SUMO conjugation contributes to immune deviation in nonobese diabetic mice by suppressing c-Maf transactivation of IL-4

Journal of Immunology

Volumn 183, Issue 2, 2009, Pages 1110-1119

  Leavenworth, Jianmei W ^a   Ma, Xiaojing ^b   Mo, Yin Yuan ^a   Pauza, Mary E ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; PROTEIN UBC9; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR C MAF; LYSINE; MAF PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL NUCLEUS; CELL STIMULATION; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONFOCAL MICROSCOPY; CYTOKINE PRODUCTION; FEMALE; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUMOYLATION; TRANSACTIVATION; WESTERN BLOTTING; ANIMAL; GENETICS; HUMAN; IMMUNITY; IMMUNOLOGY; METABOLISM; MYELOID LEUKEMIA; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL NUCLEUS; HUMANS; IMMUNITY; INTERLEUKIN-4; LEUKEMIA, MYELOID; LYSINE; MICE; MICE, INBRED NOD; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MAF; SUMO-1 PROTEIN; TRANSCRIPTIONAL ACTIVATION;

EID: 70249085630     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803671     Document Type: Article

References (67)

1. Katz, J. D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulindependent diabetes. Science 268: 1185-1188.
2. Fox, C. J., and J. S. Danska. 1997. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J. Immunol. 158: 2414-2424.
3. Rapoport, M. J., A. Mor, P. Vardi, Y. Ramot, R. Winker, A. Hindi, and T. Bistritzer. 1998. Decreased secretion of Th2 cytokines precedes up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus. J. Autoimmun. 11: 635-642.
4. Sia, C. 2005. Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus. Rev. Diabet. Stud. 2: 182-186.
5. Cameron, M. J., G. A. Arreaza, P. Zucker, S. W. Chensue, R. M. Strieter, S. Chakrabarti, and T. L. Delovitch. 1997. IL-4 prevents insulitis and insulindependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J. Immunol. 159: 4686-4692.
6. Mueller, R., L. M. Bradley, T. Krahl, and N. Sarvetnick. 1997. Mechanism underlying counterregulation of autoimmune diabetes by IL-4. Immunity 7: 411-418.
7. + T-cell responses. Nat. Med. 7: 206-214.
8. Ho, I. C., M. R. Hodge, J. W. Rooney, and L. H. Glimcher. 1996. The protooncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85: 973-983.
9. Pauza, M. E., A. Nguyen, T. Wolfe, I. C. Ho, L. H. Glimcher, M. von Herrath, and D. Lo. 2001. Variable effects of transgenic c-Maf on autoimmune diabetes. Diabetes 50: 39-46.
10. + T cells in NOD mice is related to a defect of c-Maf binding to the IL-4 promoter. Eur. J. Immunol. 35: 1408-1417.
11. Heinemeyer, T., E. Wingender, I. Reuter, H. Hermjakob, A. E. Kel, O. V. Kel, E. V. Ignatieva, E. A. Ananko, O. A. Podkolodnaya, F. A. Kolpakov, et al. 1998. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26: 362-367.
12. Verger, A., J. Perdomo, and M. Crossley. 2003. Modification with SUMO. A role in transcriptional regulation. EMBO Rep. 4: 137-142.
13. Johnson, E. S. 2004. Protein modification by SUMO. Annu. Rev. Biochem. 73: 355-382.
14. Muller, S., A. Ledl, and D. Schmidt. 2004. SUMO: a regulator of gene expression and genome integrity. Oncogene 23: 1998-2008.
15. Vertegaal, A. C., J. S. Andersen, S. C. Ogg, R. T. Hay, M. Mann, and A. I. Lamond. 2006. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell. Proteomics 5: 2298-2310.
16. Bohren, K. M., V. Nadkarni, J. H. Song, K. H. Gabbay, and D. Owerbach. 2004. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J. Biol. Chem. 279: 27233-27238.
17. Guo, D., M. Li, Y. Zhang, P. Yang, S. Eckenrode, D. Hopkins, W. Zheng, S. Purohit, R. H. Podolsky, A. Muir, et al. 2004. A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes. Nat. Genet. 36: 837-841.
18. Park, Y., S. Park, J. Kang, S. Yang, and D. Kim. 2005. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat. Genet. 37: 112; author reply 112-113.
19. Qu, H., B. Bharaj, X. Q. Liu, J. A. Curtis, L. A. Newhook, A. D. Paterson, T. J. Hudson, and C. Polychronakos. 2005. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat. Genet. 37: 111-112; author reply 112-113.
20. Smyth, D. J., J. M. Howson, C. E. Lowe, N. M. Walker, A. C. Lam, S. Nutland, J. Hutchings, E. Tuomilehto-Wolf, J. Tuomilehto, C. Guja, et al. 2005. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat. Genet. 37: 110-111; author reply 112-113.
21. +- charged talon resin. Protein Expr. Purif. 54: 289-294.
22. Peng, S., S. Lalani, J. W. Leavenworth, I. C. Ho, and M. E. Pauza. 2007. c-Maf interacts with c-Myb to down-regulate Bcl-2 expression and increase apoptosis in peripheral CD4 cells. Eur. J. Immunol. 37: 2868-2880.
23. Boggio, R., R. Colombo, R. T. Hay, G. F. Draetta, and S. Chiocca. 2004. A mechanism for inhibiting the SUMO pathway. Mol. Cell 16: 549-561.
24. Mo, Y. Y., Y. Yu, P. L. Ee, and W. T. Beck. 2004. Overexpression of a dominant-negative mutant Ubc9 is associated with increased sensitivity to anticancer drugs. Cancer Res. 64: 2793-2798.
25. Cao, S., J. Liu, L. Song, and X. Ma. 2005. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J. Immunol. 174: 3484-3492.
26. Berberich-Siebelt, F., I. Berberich, M. Andrulis, B. Santner-Nanan, M. K. Jha, S. Klein-Hessling, A. Schimpl, and E. Serfling. 2006. SUMOylation interferes with CCAAT/enhancer-binding protein β-mediated c-myc repression, but not IL-4 activation in T cells. J. Immunol. 176: 4843-4851.
27. Klibanov, S. A., H. M. O'Hagan, and M. Ljungman. 2001. Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress. J. Cell Sci. 114: 1867-1873.
28. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29: e45.
29. Rabinovitch, A. 1998. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab. Rev. 14: 129-151.
30. Yang, Y., J. Ochando, A. Yopp, J. S. Bromberg, and Y. Ding. 2005. IL-6 plays a unique role in initiating c-Maf expression during early stage of CD4 T cell activation. J. Immunol. 174: 2720-2729.
31. Boyer-Guittaut, M., K. Birsoy, C. Potel, G. Elliott, E. Jaffray, J. M. Desterro, R. T. Hay, and T. Oelgeschlager. 2005. SUMO-1 modification of human transcription factor (TF) IID complex subunits: inhibition of TFIID promoter-binding activity through SUMO-1 modification of hsTAF5. J. Biol. Chem. 280: 9937-9945.
32. Steinacher, R., and P. Schar. 2005. Functionality of human thymine DNA glycosylase requires SUMO-regulated changes in protein conformation. Curr. Biol. 15: 616-623.
33. Anckar, J., V. Hietakangas, K. Denessiouk, D. J. Thiele, M. S. Johnson, and L. Sistonen. 2006. Inhibition of DNA binding by differential sumoylation of heat shock factors. Mol. Cell. Biol. 26: 955-964.
34. Kim, K., S. Baek, and C. Chung. 2002. Versatile protein tag, SUMO: its enzymology and biological function. J. Cell. Physiol. 191: 257-268.
35. Desterro, J. M., M. S. Rodriguez, G. D. Kemp, and R. T. Hay. 1999. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J. Biol. Chem. 274: 10618-10624. (Pubitemid 129518363)
36. Matunis, M. J., E. Coutavas, and G. Blobel. 1996. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein Ran-GAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135: 1457-1470.
37. Imoto, S., N. Ohbayashi, O. Ikeda, S. Kamitani, R. Muromoto, Y. Sekine, and T. Matsuda. 2008. Sumoylation of Smad3 stimulates its nuclear export during PIASy-mediated suppression of TGF-β signaling. Biochem. Biophys. Res. Commun. 370: 359-365.
38. Panasyuk, G., I. Nemazanyy, A. Zhyvoloup, M. Bretner, D. W. Litchfield, V. Filonenko, and I. T. Gout. 2006. Nuclear export of S6K1 II is regulated by protein kinase CK2 phosphorylation at Ser-17. J. Biol. Chem. 281: 31188-31201.
39. Wilson, V. G., and D. Rangasamy. 2001. Intracellular targeting of proteins by sumoylation. Exp. Cell Res. 271: 57-65.
40. Casolaro, V., S. N. Georas, Z. Song, I. D. Zubkoff, S. A. Abdulkadir, D. Thanos, and S. J. Ono. 1995. Inhibition of NF-AT-dependent transcription by NF-κB: implications for differential gene expression in T helper cell subsets. Proc. Natl. Acad. Sci. USA 92: 11623-11627.
41. Hay, R. T. 2005. SUMO: a history of modification. Mol. Cell 18: 1-12.
42. Rapoport, M. J., T. Bistritzer, D. Aharoni, M. Weiss, Y. Ramot, A. Buchs, K. Bloch, and P. Vardi. 2005. TH1/TH2 cytokine secretion of first degree relatives of T1DM patients. Cytokine 30: 219-227.
43. Bernardi, R., and P. P. Pandolfi. 2007. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8: 1006-1016.
44. Chalkiadaki, A., and I. Talianidis. 2005. SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin. Mol. Cell. Biol. 25: 5095-5105.
45. Tan, J. A., Y. Sun, J. Song, Y. Chen, T. G. Krontiris, and L. K. Durrin. 2008. SUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavage. J. Biol. Chem. 283: 18124-18134.
46. Li, H., C. Leo, J. Zhu, X. Wu, J. O'Neil, E. J. Park, and J. D. Chen. 2000. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol. Cell. Biol. 20: 1784-1796.
47. Valanciute, A., S. le Gouvello, B. Solhonne, A. Pawlak, P. Grimbert, L. Lyonnet, S. Hue, P. Lang, P. Remy, R. Salomon, et al. 2004. NF-κB p65 antagonizes IL-4 induction by c-maf in minimal change nephrotic syndrome. J. Immunol. 172: 688-698.
48. Matunis, M. J., J. Wu, and G. Blobel. 1998. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J. Cell Biol. 140: 499-509.
49. Song, J., L. K. Durrin, T. A. Wilkinson, T. G. Krontiris, and Y. Chen. 2004. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl. Acad. Sci. USA 101: 14373-14378.
50. Valin, A., and G. Gill. 2007. Regulation of the dual-function transcription factor Sp3 by SUMO. Biochem. Soc. Trans. 35: 1393-1396.
51. Chang, C. C., D. Y. Lin, H. I. Fang, R. H. Chen, and H. M. Shih. 2005. Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4. J. Biol. Chem. 280: 10164-10173.
52. Kuo, H. Y., C. C. Chang, J. C. Jeng, H. M. Hu, D. Y. Lin, G. G. Maul, R. P. Kwok, and H. M. Shih. 2005. SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx. Proc. Natl. Acad. Sci. USA 102: 16973-16978.
53. Baguet, A., and M. Bix. 2004. Chromatin landscape dynamics of the Il4-Il13 locus during T helper 1 and 2 development. Proc. Natl. Acad. Sci. USA 101: 11410-11415.
54. Ansel, K. M., I. Djuretic, B. Tanasa, and A. Rao. 2006. Regulation of Th2 differentiation and Il4 locus accessibility. Annu. Rev. Immunol. 24: 607-656.
55. Miner, K. T., and M. Croft. 1998. Generation, persistence, and modulation of Th0 effector cells: role of autocrine IL-4 and IFN-γ. J. Immunol. 160: 5280-5287.
56. Avni, O., D. Lee, F. Macian, S. J. Szabo, L. H. Glimcher, and A. Rao. 2002. TH cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat. Immunol. 3: 643-651.
57. Berberich-Siebelt, F., S. Klein-Hessling, N. Hepping, B. Santner-Nanan, D. Lindemann, A. Schimpl, I. Berberich, and E. Serfling. 2000. C/EBPβ enhances IL-4 but impairs IL-2 and IFN-γ induction in T cells. Eur. J. Immunol. 30: 2576-2585.
58. Garaude, J., R. Farras, G. Bossis, S. Charni, M. Piechaczyk, R. A. Hipskind, and M. Villalba. 2008. SUMOylation regulates the transcriptional activity of JunB in T lymphocytes. J. Immunol. 180: 5983-5990.
59. Zhao, X., B. Zheng, Y. Huang, D. Yang, S. Katzman, C. Chang, D. Fowell, and W. P. Zeng. 2007. Interaction between GATA-3 and the transcriptional coregulator Pias1 is important for the regulation of Th2 immune responses. J. Immunol. 179: 8297-8304.
60. Collavin, L., M. Gostissa, F. Avolio, P. Secco, A. Ronchi, C. Santoro, and G. Del Sal. 2004. Modification of the erythroid transcription factor GATA-1 by SUMO-1. Proc. Natl. Acad. Sci. USA 101: 8870-8875.
61. Kaufman, R. J., D. Scheuner, M. Schroder, X. Shen, K. Lee, C. Y. Liu, and S. M. Arnold. 2002. The unfolded protein response in nutrient sensing and differentiation. Nat. Rev. Mol. Cell Biol. 3: 411-421.
62. Hietakangas, V., J. K. Ahlskog, A. M. Jakobsson, M. Hellesuo, N. M. Sahlberg, C. I. Holmberg, A. Mikhailov, J. J. Palvimo, L. Pirkkala, and L. Sistonen. 2003. Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol. Cell. Biol. 23: 2953-2968.
63. Kurepa, J., J. M. Walker, J. Smalle, M. M. Gosink, S. J. Davis, T. L. Durham, D. Y. Sung, and R. D. Vierstra. 2003. The small ubiquitin-like modifier (SUMO) protein modification system in Arabidopsis. Accumulation of SUMO1 and -2 conjugates is increased by stress. J. Biol. Chem. 278: 6862-6872.
64. Liu, Z., and T. M. Aune. 2006. Deregulated stress system in non-obese diabetic lymphocyte. Genes Immun. 7: 352-358. (Pubitemid 44111639)
65. Steffan, J. S., N. Agrawal, J. Pallos, E. Rockabrand, L. C. Trotman, N. Slepko, K. Illes, T. Lukacsovich, Y. Z. Zhu, E. Cattaneo, et al. 2004. SUMO modification of Huntingtin and Huntington's disease pathology. Science 304: 100-104.
66. Alkuraya, F. S., I. Saadi, J. J. Lund, A. Turbe-Doan, C. C. Morton, and R. L. Maas. 2006. SUMO1 haploinsufficiency leads to cleft lip and palate. Science 313: 1751.
67. Kim, J. H., J. M. Lee, H. J. Nam, H. J. Choi, J. W. Yang, J. S. Lee, M. H. Kim, S. I. Kim, C. H. Chung, K. I. Kim, and S. H. Baek. 2007. SUMOylation of pontin chromatin-remodeling complex reveals a signal integration code in prostate cancer cells. Proc. Natl. Acad. Sci. USA 104: 20793-20798.